心玮医疗-B(06609)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06609 心玮医疗-B

已收盘 04-08 16:08:18

54.500

+6.340

+13.16%

最高56.700	最低48.780	成交量31.72万
今开48.160	昨收48.160	日振幅16.45%
总市值20.63亿	流通市值16.67亿	总股本3,786万
成交额1,720万	换手率1.04%	流通股本3,059万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06609","market":"HK","secType":"STK","nameCN":"心玮医疗-B","latestPrice":54.5,"timestamp":1775635698226,"preClose":48.16,"halted":0,"volume":317200,"delay":0,"changeRate":0.13164451827242532,"floatShares":30593400,"shares":37862000,"eps":2.5241717003157293,"marketStatus":"已收盘","change":6.34,"latestTime":"04-08 16:08:18","open":48.16,"high":56.7,"low":48.78,"amount":17202298,"amplitude":0.164452,"askPrice":55.3,"askSize":1700,"bidPrice":54.5,"bidSize":100,"shortable":0,"etf":0,"ttmEps":2.5241717003157293,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775698200000},"marketStatusCode":5,"adr":0,"listingDate":1629388800000,"exchange":"SEHK","adjPreClose":48.16,"openAndCloseTimeList":[[1775611800000,1775620800000],[1775624400000,1775635200000]],"volumeRatio":3.540179,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06609","defaultTab":"news","newsList":[{"id":"1169539800","title":"心玮医疗-B更新3月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1169539800","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169539800?lang=zh_cn&edition=full","pubTime":"2026-04-02 15:46","pubTimestamp":1775115988,"startTime":"0","endTime":"0","summary":"心玮医疗-B（股票代码：06609）于2026年4月2日披露的截至2026年3月31日的股份变动月报表显示，公司本月无新增发行、购回或注销活动，股本结构维持稳定。\n根据公告，截至2026年3月31日，公司注册股本总额为人民币38,834,408元，包含31,565,804股已在香港联交所上市的H股，以及7,268,604股非上市股份。两类股份本月均未发生变动。H股在本月末的已发行股份数量为30,593,404股，另有972,400股作为库存股份持有。\n公告信息显示，该公司确认符合香港联交所《上市规则》的最低公众持股量要求。本次月报由公司董事王国辉签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624597075","title":"首次实现年度高质量盈利，心玮医疗-B(06609)迎业绩拐点与估值修复双重逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2624597075","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624597075?lang=zh_cn&edition=full","pubTime":"2026-04-01 19:06","pubTimestamp":1775041600,"startTime":"0","endTime":"0","summary":"近日，心玮医疗-B2025年年度业绩正式出炉。报告期内，该产品已进入超过450家医院，头部医院渗透率达26%，带动销量增长约300%。除了现金牛业务的稳健表现外，心玮医疗2025年的出血业务“显著增量”也是财报中的一大亮点。而期内血流导向装置的获批上市，则进一步补齐心玮出血业务的重要拼图。与此同时，期内首次实现年度盈利，也预示着心玮医疗已稳步进入“创新-盈利”正循环。目前心玮医疗的海外业务还在有序开展，产品注册稳步推进。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424122.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"首次实现年度高质量盈利，心玮医疗-B(06609)迎业绩拐点与估值修复双重逻辑","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1587","BK1100","06609","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147314330","title":"异动解读 | 业绩扭亏为盈且增长强劲，心玮医疗-B盘中大涨5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=1147314330","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147314330?lang=zh_cn&edition=full","pubTime":"2026-03-30 13:29","pubTimestamp":1774848546,"startTime":"0","endTime":"0","summary":"心玮医疗-B今日盘中股价大幅上涨5.35%，引起了市场的广泛关注。消息面上，公司此前发布的2025年年度业绩显示其成功实现重大扭亏为盈。报告期内，公司实现营业收入4.08亿元，同比增长46.9%；净利润达到8334万元，相较2024年的亏损1362万元，业绩表现显著改善。公司的增长动力来自缺血性、出血性卒中及介入通路三大业务板块的梯次发力，其中出血性卒中业务收入同比暴增223.2%。海外市场拓展迅速，收入同比增长101.3%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622856847","title":"业绩会直击|心玮医疗-B（6609.HK）：2025迈入规模化盈利，全球化与研发管线双维突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2622856847","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622856847?lang=zh_cn&edition=full","pubTime":"2026-03-27 17:50","pubTimestamp":1774605002,"startTime":"0","endTime":"0","summary":"2025年公司实现营收4.08亿元，同比增长46.9%，过去五年营收CAGR达46%；归母净利润为8334万元，成功扭亏为盈，相较上年度净亏损约1362万元改善幅度超710%。","market":"fut","thumbnail":"https://img7.gelonghui.com/column/2/110.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/110.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4218654","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1574","BK1587","06609","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104991201","title":"心玮医疗-B 2025年营收大幅增长并实现年度盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=1104991201","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104991201?lang=zh_cn&edition=full","pubTime":"2026-03-26 18:54","pubTimestamp":1774522441,"startTime":"0","endTime":"0","summary":"于2025年，心玮医疗-B实现收入人民币4.08亿元，同比上升46.9%。毛利额为人民币2.90亿元，较上一年度增长59.3%，毛利率由65.4%提升至70.9%。销售及分销及行政开支合计为人民币1.87亿元，同比增长35.8%。研发成本为人民币4,076.10万元，除税前利润由人民币-1,199.20万元上升至人民币8,640.80万元，年内利润及全面收益总额达到人民币8,333.50万元。现金及银行结余年末为人民币5.90亿元，略低于上一年度的人民币6.02亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622859250","title":"心玮医疗-B(06609)发布年度业绩 股东应占溢利8333.5万元 出血性卒中业务收入同比大幅增长223.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622859250","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622859250?lang=zh_cn&edition=full","pubTime":"2026-03-26 18:50","pubTimestamp":1774522247,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心玮医疗-B 发布截至2025年12月31日止年度业绩，该集团取得收益4.08亿元，同比增长46.9%;毛利2.9亿元，同比增长59.3%;研发成本4076.1万元，同比减少30.8%;股东应占溢利8333.5万元，同比扭亏为盈;每股基本盈利2.21元。于2025财政年度，公司取得收益人民币4.083亿元，同比增长46.9%。集团取得股东应占净利润人民币8333.5万元，较上年度的股东应占净亏损约人民币1360万元实现重大扭亏为盈。基于前述原因，公司的出血性卒中业务收入在2025年同比增长223.2%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419627.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1587","06609","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619445627","title":"心玮医疗-B(06609.HK)3月26日举行董事会会议审议及批准全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2619445627","media":"中金财经","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619445627?lang=zh_cn&edition=full","pubTime":"2026-03-16 17:27","pubTimestamp":1773653222,"startTime":"0","endTime":"0","summary":"格隆汇3月16日丨心玮医疗-B(06609.HK)宣布，公司将于2026年3月26日(星期四)举行董事会会议，藉以(其中包括)审议及批准公司及其附属公司截至2025年12月31日止年度之全年业绩及其发布，以及考虑建议派付末期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260316/32071682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1587","BK1574","06609","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618989114","title":"心玮医疗-B盘中异动 股价大涨5.47%报43.980港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618989114","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618989114?lang=zh_cn&edition=full","pubTime":"2026-03-10 13:00","pubTimestamp":1773118803,"startTime":"0","endTime":"0","summary":"2026年03月10日下午盘13时00分，心玮医疗-B股票出现波动，股价快速上涨5.47%。截至发稿，该股报43.980港元/股，成交量12.615万股，换手率0.41%，振幅4.56%。资金方面，该股资金流入228.145万港元，流出223.283万港元。心玮医疗-B股票所在的医疗设备及用品行业中，整体涨幅为0.20%。其相关个股中，紫元元、归创通桥、心玮医疗-B涨幅较大，振幅较大的相关个股有紫元元、京玖康疗、普华和顺，振幅分别为40.00%、11.67%、11.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031013000395468c11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031013000395468c11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","06609","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614420853","title":"心玮医疗-B盘中异动 急速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614420853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614420853?lang=zh_cn&edition=full","pubTime":"2026-02-27 15:15","pubTimestamp":1772176518,"startTime":"0","endTime":"0","summary":"2026年02月27日下午盘15时15分，心玮医疗-B股票出现波动，股价急速拉升5.10%。截至发稿，该股报45.300港元/股，成交量8500股，换手率0.03%，振幅5.29%。心玮医疗-B股票所在的医疗设备及用品行业中，整体跌幅为0.13%。其相关个股中，京玖康疗、爱康医疗、华检医疗涨幅较大，振幅较大的相关个股有京玖康疗、GUANZE MEDICAL、隽泰控股，振幅分别为17.86%、15.68%、13.99%。心玮医疗-B公司简介：上海心玮医疗科技股份有限公司是从事创新型神经介入医疗器械研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227151518a4ceb997&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227151518a4ceb997&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1100","06609","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611526791","title":"心玮医疗-B盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611526791","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611526791?lang=zh_cn&edition=full","pubTime":"2026-02-13 09:43","pubTimestamp":1770947021,"startTime":"0","endTime":"0","summary":"2026年02月13日早盘09时43分，心玮医疗-B股票出现波动，股价快速下跌5.11%。截至发稿，该股报46.020港元/股，成交量2150股，换手率0.01%，振幅1.86%。资金方面，该股资金流入0港元，流出9.7144万港元。心玮医疗-B股票所在的医疗设备及用品行业中，整体涨幅为0.10%。其相关个股中，GUANZE MEDICAL、微创机器人-B、华检医疗涨幅较大，振幅较大的相关个股有GUANZE MEDICAL、健世科技-B、百心安-B，振幅分别为12.23%、7.16%、7.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213094341a49e8c0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213094341a49e8c0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06609","BK1587","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606296102","title":"心玮医疗-B盘中异动 早盘股价大跌6.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606296102","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606296102?lang=zh_cn&edition=full","pubTime":"2026-01-26 10:12","pubTimestamp":1769393541,"startTime":"0","endTime":"0","summary":"2026年01月26日早盘10时12分，心玮医疗-B股票出现波动，股价大幅跳水6.63%。截至发稿，该股报53.500港元/股，成交量1.85万股，换手率0.06%，振幅6.46%。资金方面，该股资金流入27.3435万港元，流出69.8865万港元。心玮医疗-B股票所在的医疗设备及用品行业中，整体跌幅为0.72%。其相关个股中，GUANZE MEDICAL、现代牙科、今海医疗科技涨幅较大，振幅较大的相关个股有GUANZE MEDICAL、紫元元、华检医疗，振幅分别为29.21%、11.11%、10.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012610122197a3556f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012610122197a3556f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","06609","BK1574","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605461638","title":"心玮医疗-B(06609)1月22日斥资224.3万港元回购4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2605461638","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605461638?lang=zh_cn&edition=full","pubTime":"2026-01-22 17:22","pubTimestamp":1769073777,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心玮医疗-B(06609)发布公告，于2026年1月22日，该公司斥资224.3万港元回购4万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396184.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","06609","BK1574","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605430681","title":"税前利润增幅近800%，心玮医疗-B（6609.HK）凭硬实力领跑神经介入赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2605430681","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605430681?lang=zh_cn&edition=full","pubTime":"2026-01-22 09:19","pubTimestamp":1769044773,"startTime":"0","endTime":"0","summary":"心玮医疗披露2025年度正面盈利预告，全年营收与利润实现跨越式增长，正式迈入盈利区间。","market":"sh","thumbnail":"https://img7.gelonghui.com/column/3.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/3.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/3640219","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["06609","BK1587","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605171270","title":"多重利好加身心玮医疗大涨14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605171270","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605171270?lang=zh_cn&edition=full","pubTime":"2026-01-21 14:55","pubTimestamp":1768978500,"startTime":"0","endTime":"0","summary":"心玮医疗-B股价早盘大涨14%至57.85港元，主要受多重利好消息推动。公司预计2025年度收益将达4亿至4.1亿元人民币，较2024年增长至少43.9%，并实现除税前利润约8000万元，较2024年的净亏损1200万元有显著改善。此外，公司开发的自膨式颅内药物洗脱支架已获国家药品监督管理局受理注册申请，该产品用于治疗颅内动脉粥样硬化性狭窄，具有支撑和开通管腔、预防再狭窄的作用。目前全球尚无类似产品获批上市，公司在该领域的研发进度处于行业领先地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121145718a4446963&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121145718a4446963&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1587","06609","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605171276","title":"扭亏为盈，股价劲升9.5%，心玮医疗进入业绩拐点？","url":"https://stock-news.laohu8.com/highlight/detail?id=2605171276","media":"港股解码","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605171276?lang=zh_cn&edition=full","pubTime":"2026-01-21 13:26","pubTimestamp":1768973183,"startTime":"0","endTime":"0","summary":"1月20日，心玮医疗宣布，旗下开发的自膨式颅内药物洗脱支架的注册申请已获国家药监局受理。据了解，自膨式颅内药物洗脱支架用于颅内动脉粥样硬化性狭窄的治疗，对狭窄和梗阻的管腔具有支撑和开通的作用，并且能有效预防支架内的管腔再狭窄。若其开发的自膨式颅内药物洗脱支架后续顺利通过审批并成功上市，将填补全球相关领域的市场空白，为公司开辟全新增长曲线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121132922a444219c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121132922a444219c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1587","BK1574","06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604609111","title":"心玮医疗-B(06609)发盈喜 预期2025年收益约4亿元至4.1亿元 同比增加至少43.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604609111","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604609111?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:28","pubTimestamp":1768919293,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心玮医疗-B 发布公告，集团预期于截至2025年12月31日止年度取得收益介乎约人民币4亿元至人民币4.1亿元，较截至2024年12月31日止年度的收益人民币2.78亿元增加至少43.9%。集团亦预计于报告期间取得除税前利润约人民币8000万元，与截至2024年12月31日止年度的除税前净亏损人民币1200万元比较有大幅增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1395307.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"心玮医疗-B(06609)发盈喜 预期2025年收益约4亿元至4.1亿元 同比增加至少43.9%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","06609","BK1587","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185849187","title":"心玮医疗-B：自膨式颅内药物洗脱支架注册申请获国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=1185849187","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185849187?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:19","pubTimestamp":1768918778,"startTime":"0","endTime":"0","summary":"心玮医疗-B（股票代码：06609）宣布，其自主研发的自膨式颅内药物洗脱支架注册申请已正式获得中国国家药品监督管理局（NMPA）受理。这一进展标志着公司在神经介入领域的创新产品线取得重要突破，为后续商业化进程奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609","BK1574","BK1587","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604111853","title":"心玮医疗-B(06609)：自膨式颅内药物洗脱支架的注册申请获国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2604111853","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604111853?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:19","pubTimestamp":1768918777,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心玮医疗-B(06609)发布公告，本集团开发的自膨式颅内药物洗脱支架的注册申请已获中国国家药品监督管理局(国家药监局)受理。自膨式颅内药物洗脱支架用于颅内动脉粥样硬化性狭窄的治疗，对狭窄和梗阻的管腔具有支撑和开通的作用，并且能有效预防支架内的管腔再狭窄。根据公开信息查询，目前全球范围内尚无类似产品获批上市，本公司对该类型产品的研发进度处于行业内领先水平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1395303.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"心玮医疗-B(06609)：自膨式颅内药物洗脱支架的注册申请获国家药监局受理","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1574","06609","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604311679","title":"心玮医疗-B盘中异动 快速跳水5.36%报51.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604311679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604311679?lang=zh_cn&edition=full","pubTime":"2026-01-20 14:07","pubTimestamp":1768889269,"startTime":"0","endTime":"0","summary":"2026年01月20日下午盘14时07分，心玮医疗-B股票出现波动，股价急速跳水5.36%。截至发稿，该股报51.200港元/股，成交量5.83万股，换手率0.19%，振幅5.18%。资金方面，该股资金流入89.3692万港元，流出193.656万港元。心玮医疗-B股票所在的医疗设备及用品行业中，整体跌幅为0.31%。其相关个股中，紫元元、巨星医疗控股、现代牙科涨幅较大，振幅较大的相关个股有紫元元、佳兆业健康、巨星医疗控股，振幅分别为15.79%、10.84%、8.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120140749a72f40c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120140749a72f40c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06609","BK1100","BK1587","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604886861","title":"华金证券：政策引领叠加技术突破 脑机接口商业化可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2604886861","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604886861?lang=zh_cn&edition=full","pubTime":"2026-01-19 14:34","pubTimestamp":1768804453,"startTime":"0","endTime":"0","summary":"华金证券主要观点如下：脑机接口产业快速发展，国产厂商加速布局据中研普华产业研究院预测，2022年中国脑机接口市场规模约为10亿元人民币，年均复合增长率约为21%，市场发展潜力巨大。政策引领叠加技术突破，推动行业快速发展，加速脑机接口商业化进程。投资建议华金证券认为，脑机接口产业进入商业化落地关键元年，政策引领、技术迭代叠加临床突破共振，推动行业快速发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394429.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161027","BK1587","BK1574","BK1100","06609"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.strokemedical.com","stockEarnings":[{"period":"1week","weight":0.0921},{"period":"1month","weight":0.1289},{"period":"3month","weight":-0.1179},{"period":"6month","weight":-0.3061},{"period":"1year","weight":0.6693},{"period":"ytd","weight":-0.1032}],"compareEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0253},{"period":"3month","weight":-0.0464},{"period":"6month","weight":-0.0746},{"period":"1year","weight":0.0825},{"period":"ytd","weight":-0.0201}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海心玮医疗科技股份有限公司是一家主要从事医疗器械研发、生产和商业化的中国公司。该公司的主要神经介入产品及在研产品包括缺血性脑卒中取栓器械，如Captor取栓器械和颅内血栓抽吸导管，颅内动脉狭窄治疗器械，如颅内球囊扩张导管及颈动脉球囊扩张导管和栓塞保护系统，出血性脑卒中治疗器械，如颅内动脉瘤栓塞辅助支架和血流导向装置，缺血性脑卒中预防器械，如左心耳封堵器，以及血管通路器械如远端通路导管、微导管、封堵球囊导管等。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.1064},{"month":2,"riseRate":0.4,"avgChangeRate":-0.067342},{"month":3,"riseRate":0.4,"avgChangeRate":-0.0145},{"month":4,"riseRate":0.4,"avgChangeRate":-0.03955},{"month":5,"riseRate":0.25,"avgChangeRate":-0.041514},{"month":6,"riseRate":0.5,"avgChangeRate":0.086836},{"month":7,"riseRate":0.5,"avgChangeRate":0.065893},{"month":8,"riseRate":0.5,"avgChangeRate":-0.063767},{"month":9,"riseRate":0.6,"avgChangeRate":0.057771},{"month":10,"riseRate":0.4,"avgChangeRate":-0.058186},{"month":11,"riseRate":0.4,"avgChangeRate":0.057501},{"month":12,"riseRate":0.8,"avgChangeRate":0.076512}],"exchange":"SEHK","name":"心玮医疗-B","nameEN":"HEARTCARE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"心玮医疗-B(06609)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供心玮医疗-B(06609)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"心玮医疗-B,06609,心玮医疗-B股票,心玮医疗-B股票老虎,心玮医疗-B股票老虎国际,心玮医疗-B行情,心玮医疗-B股票行情,心玮医疗-B股价,心玮医疗-B股市,心玮医疗-B股票价格,心玮医疗-B股票交易,心玮医疗-B股票购买,心玮医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"心玮医疗-B(06609)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供心玮医疗-B(06609)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}